Original Article

You have full text access to this OnlineOpen article

Management of nonsinonasal neuroendocrine carcinomas of the head and neck

  1. Jerry L. Barker Jr. M.D.1,
  2. Bonnie S. Glisson M.D.2,
  3. Adam S. Garden M.D.1,
  4. Adel K. El-Naggar M.D.3,
  5. William H. Morrison M.D.1,
  6. K. Kian Ang M.D., Ph.D.1,
  7. K. S. Clifford Chao M.D.1,
  8. Gary Clayman M.D.4,
  9. David I. Rosenthal M.D.1,†,*

Article first published online: 22 OCT 2003

DOI: 10.1002/cncr.11795

Issue

Cancer

Cancer

Volume 98, Issue 11, pages 2322–2328, 1 December 2003

Additional Information

How to Cite

Barker, J. L., Glisson, B. S., Garden, A. S., El-Naggar, A. K., Morrison, W. H., Ang, K. K., Chao, K. S. C., Clayman, G. and Rosenthal, D. I. (2003), Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer, 98: 2322–2328. doi: 10.1002/cncr.11795

Author Information

  1. 1

    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  3. 3

    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  4. 4

    Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. †

    Fax: (713) 563-2336

*Department of Radiation Oncology, Unit 97, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030

Publication History

  1. Issue published online: 17 NOV 2003
  2. Article first published online: 22 OCT 2003
  3. Manuscript Accepted: 26 AUG 2003
  4. Manuscript Received: 10 JUL 2003

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (133K)

REFERENCES

  • 1
    Rosenthal DI, Barker JL, El-Naggar AK, et al. Sinonasal carcinoma with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Forty-Fifth Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Salt Lake City, UT, October 19–23, 2003.
  • 2
    Levine PA, Frierson HF, Stewart FM, et al. Sinonasal undifferentiated carcinoma: a distinctive and highly aggressive neoplasm. Laryngoscope. 1987; 97: 905–908.
  • 3
    Deutsch BD, Levine PA, Stewart FM, et al. Sinonasal undifferentiated carcinoma: a ray of hope. Otolaryngol Head Neck Surg. 1993; 108: 697–700.
  • 4
    Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 1993; 27: 835–842.
  • 5
    Chao KS, Kaplan C, Simpson JR, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck. 2001; 23: 749–757.
    Direct Link:
  • 6
    Ferlito A, Barnes L, Rinaldo A, et al. A review of neuroendocrine neoplasms of the larynx: update on diagnosis and treatment. J Laryngol Otol. 1998; 112: 827–834.
  • 7
    FlemingID, CooperJS, HensonDE, et al., editors. AJCC cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven, 1997: 149–156.
  • 8
    Mills SE. Neuroectodermal neoplasms of the head and neck with emphasis on neuroendocrine carcinomas. Mod Pathol. 2002; 15: 264–278.
  • 9
    Barnes L. Paraganglioma of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec. 1991; 53: 220–234.
  • 10
    El-Naggar AK, Batsakis JG, Vasilopoulou-Sellin R, et al. Medullary (thyroid) carcinoma-like carcinoids of the larynx. J Laryngol Otol. 1991; 105: 683–686.
  • 11
    Paulino AF, Singh B, Shah JP, et al. Basaloid squamous cell carcinoma of the head and neck. Laryngoscope. 2000; 110: 1479–1482.
    Direct Link:
  • 12
    Reuter VE, Woodruff JM. Melanoma of the larynx. Laryngoscope. 1986; 94: 389–393.
  • 13
    Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer. 1997; 79: 804–812.
    Direct Link:
  • 14
    Silva EG, Mackay B, Goepfert H, et al. Endocrine carcinoma of the skin (Merkel cell carcinoma). Pathol Annu. 1984; 19: 1–30.
  • 15
    Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31: 1341–1346.
  • 16
    Tabbara IA, Levine PA. Small-cell carcinoma of the head and neck: a novel treatment regimen. Am J Clin Oncol. 1991; 14: 416–418.
  • 17
    Aguilar EA, Robbins KT, Stephens J, et al. Primary oat cell carcinoma of the larynx. Am J Clin Oncol. 1987; 10: 26–32.
  • 18
    Mills SE, Cooper PH, Garland TA, et al. Small cell undifferentiated carcinoma of the larynx: report of two patients and review of thirteen additional cases. Cancer. 1983; 51: 116–120.
    Direct Link:
  • 19
    Kasimis BS, Wuerker RB, Malefatto JP, et al. Prolonged survival of patients with extrapulmonary small cell carcinoma arising in the neck. Med Pediatr Oncol. 1983; 11: 27–32.
    Direct Link:
  • 20
    Remick SC, Hafez GR, Carbone PP. Extrapulmonary small-cell carcinoma: a review of the literature with emphasis on therapy and outcome. Medicine (Baltimore). 1987; 66: 457–471.
  • 21
    Machtay M, Kaiser LR, Glatstein E. Is meta-analysis really meta-physics? Chest. 1999; 116: 539–542.
  • 22
    Ettinger D, Seiferheld W, Abrams R, et al. Cisplatin (P), etoposide (E), paclitaxel (T) and concurrent hyperfractionated thoracic radiotherapy (TRT) for patients (Pts) with limited disease (LD) small cell lung cancer (SCLC): preliminary results of RTOG 96-09 [abstract]. Proc Am Soc Clin Oncol. 2000; 19: 490a.
  • 23
    Fu K, Pajak T, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 90-03. Int J Radiat Oncol Biol Phys. 2000; 48: 7–16.
  • 24
    Boushey RP, Dackiw AP. Carcinoid tumors. Curr Treat Options Oncol. 2002; 3: 319–326.
  • 25
    Murray N, Coy P, Pater JL, et al. The importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small cell lung cancer. J Clin Oncol. 1993; 11: 336–344.
  • 26
    Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999; 340: 265–271.
  • 27
    Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol. 2002; 20: 3054–3060.
  • 28
    Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med. 1999; 341: 476–484.
  • 29
    Russell AH, Pajak TE, Selim HM, et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1991; 21: 637–643.
  • 30
    Umsawasdi T, Valdivieso M, Chen TT, et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol. 1984; 2: 253–259.
  • 31
    Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. Eur J Cancer. 1997; 33: 1752–1758.
  • 32
    Ohonoshi T, Ueoka H, Kawahara S, et al. Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response: a long-term follow-up result. Lung Cancer. 1993; 10: 47–54.
  • 33
    Turrisi AT. Brain irradiation and systemic chemotherapy for small-cell lung cancer: dangerous liaisons? J Clin Oncol. 1990; 8: 196–199.
View Full Article (HTML) Get PDF (133K)